Signs of childhood brain cancer parents should look out for as NHS approves new treatment

The National Institute for Health and Care Excellence (NICE) has approved the use of a combination of dabrafenib and trametinib for treatment of gliomas in children and young people

Related Keywords

Peter Abel ,University Of Central Lancashire ,National Institute For Health ,See Pa Feature ,Pa Feature ,National Institute ,Care Excellence ,Carolina Goncalves ,Ana Carolina ,Central Lancashire ,Nhs ,Nice ,Cancer ,